29 results

• EU Regulators Warn About Possible Risk of Thyroid Cancer From Ozempic, Wegovy and Other Diabetes Drugs

  June 23, 2023

  Irvin Jackson

  Some diabetes drugs, like Ozempic and Wegovy, may be linked to increased thyroid cancer risks, European drug regulators warn.

• Elevated Cancer Rates Among U.S. Military Pilots and Ground Crew Highlighted in New Study

  April 5, 2023

  Irvin Jackson

  A study by the Department of Defense has found higher rates of cancer among military aircrew and ground crew, raising questions about the potential causes.

• Thyroid Cancer Risk Linked to Paraquat, Roundup and Other Pesticides: Study

  September 30, 2022

  Irvin Jackson

  A new study warns that a third of pesticides may increase thyroid cancer risks through residential use.

• One-Third Of Thyroid Ultrasounds May Be Unnecessary: Study

  August 26, 2020

  Martha Garcia

  A new study finds that many thyroid ultrasounds are unnecessary and ordered by doctors who did not follow clinical guidelines.

• Flame Retardants May Increase Risk of Papillary Thyroid Cancer: Study

  April 3, 2017

  Martha Garcia

  A new study's findings suggest that flame retardants can increase the risk of thyroid cancer.

• Lipitor, Crestor, Other Statins May Increase Thyroid Cancer Risks In Women: Study

  December 17, 2014

  Irvin Jackson

  A new study links thyroid cancer in women to regular use of statins like Lipitor and Crestor.

• New Diabetic Drug Similar to Byetta, Victoza Approved, Despite Cancer Risks

  September 19, 2014

  Irvin Jackson

  The FDA has approved a new diabetes drug, Trulicity, that may carry similar thyroid and pancreatic cancer risks as existing diabetes treatments.

• Victoza Risks Make it Bad Drug for Weight-Loss, Consumer Group Warns FDA

  September 17, 2014

  Irvin Jackson

  Public Citizen is urging the FDA to reject calls to use the diabetes drug Victoza as a weight loss drug, saying it is already too dangerous as a diabetes drug, posing a risk of cancer, pancreatitis and heart problems.

• Motion to Establish Byetta MDL for Thyroid Cancer Lawsuits Withdrawn

  February 20, 2014

  Irvin Jackson

  A request that Byetta thyroid cancer lawsuits be included in diabetes drug pancreatic cancer litigation has been suddenly withdrawn.